TG Therapeutics Inc (TGTX.OQ)
TGTX.OQ on NASDAQ Stock Exchange Capital Market
5.12USD
10 Dec 2018
5.12USD
10 Dec 2018
Change (% chg)
$0.12 (+2.40%)
$0.12 (+2.40%)
Prev Close
$5.00
$5.00
Open
$5.00
$5.00
Day's High
$5.16
$5.16
Day's Low
$4.87
$4.87
Volume
276,830
276,830
Avg. Vol
395,664
395,664
52-wk High
$17.30
$17.30
52-wk Low
$4.20
$4.20
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 0.04 | -0.434 |
| Jun '18 | 0.04 | -0.594 | |
| Mar '18 | 0.04 | -0.588 | |
| FY 2017 | Dec '17 | 0.04 | -0.463 |
| Sep '17 | 0.04 | -0.485 | |
| Jun '17 | 0.04 | -0.448 | |
| Mar '17 | 0.04 | -0.522 | |
| FY 2016 | Dec '16 | 0.04 | -0.480 |
| Sep '16 | 0.04 | -0.505 | |
| Jun '16 | 0.04 | -0.326 | |
| Mar '16 | 0.04 | -0.283 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 5 | 0.03 | 0.04 | 0.00 | 0.02 |
| Quarter Ending Mar-19 | 1 | 0.04 | 0.04 | 0.04 | -- |
| Year Ending Dec-18 | 5 | 0.12 | 0.15 | 0.00 | 1.77 |
| Year Ending Dec-19 | 5 | 0.12 | 0.16 | 0.00 | 17.77 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 5 | -0.44 | -0.41 | -0.49 | -0.42 |
| Quarter Ending Mar-19 | 2 | -0.37 | -0.30 | -0.43 | -- |
| Year Ending Dec-18 | 5 | -2.03 | -1.98 | -2.10 | -1.71 |
| Year Ending Dec-19 | 5 | -1.60 | -0.96 | -2.06 | -1.95 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 92.25 | 33.63 | |
| P/E High - Last 5 Yrs. | -- | 323.36 | 45.43 | |
| P/E Low - Last 5 Yrs. | -- | 90.29 | 24.43 | |
| Beta | 1.34 | 0.91 | 0.90 | |
| Price to Sales (TTM) | 5,555.65 | 116.41 | 5.77 | |
| Price to Book (MRQ) | 10.74 | 15.60 | 5.12 | |
| Price to Tangible Book (MRQ) | 10.97 | 14.89 | 6.54 | |
| Price to Cash Flow (TTM) | -- | 72.75 | 23.57 | |
| % Owned Institutions | 57.66 | 12.59 | 1.83 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.39 | 1.49 | |
| Dividend Yield - 5 Year Avg | -- | 0.31 | 1.50 | |
| Dividend 5 Year Growth Rate | -- | 2.65 | 5.08 | |
| Payout Ratio(TTM) | -- | 23.68 | 43.75 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 0.00 | 358.89 | 7.43 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 0.00 | 90.38 | 5.80 | |
| Sales - 5 Yr. Growth Rate | -- | 31.32 | 10.19 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -37.42 | 36.71 | 21.03 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -55.17 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 39.68 | 10.79 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 39.59 | 15.12 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.98 | 2.28 |
| Current Ratio (MRQ) | 4.67 | 5.42 | 3.11 |
| LT Debt to Equity (MRQ) | 0.00 | 33.58 | 11.47 |
| Total Debt to Equity (MRQ) | 0.20 | 35.41 | 15.63 |
| Interest Coverage (TTM) | -- | -152.89 | 31.38 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 41.87 | 54.21 | |
| Gross Margin - 5 Yr. Avg. | -- | 49.14 | 51.98 | |
| EBITD Margin (TTM) | -68,874.41 | -- | -- | |
| EBITD - 5 Yr. Avg | -38,777.75 | -506.71 | 11.83 | |
| Operating Margin (TTM) | -68,927.37 | -728.63 | 4.90 | |
| Operating Margin - 5 Yr. Avg. | -39,411.89 | -526.19 | 7.44 | |
| Pre-Tax Margin (TTM) | -68,625.83 | -694.90 | 5.91 | |
| Pre-Tax Margin - 5 Yr. Avg. | -38,709.13 | -531.06 | 7.89 | |
| Net Profit Margin (TTM) | -68,625.83 | -696.67 | 2.16 | |
| Net Profit Margin - 5 Yr. Avg. | -38,761.63 | -534.50 | 4.12 | |
| Effective Tax Rate (TTM) | -- | 25.12 | 23.36 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 20.63 | 24.15 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 2,381 | 25,687,363 | 898,926,015 | |
| Net Income/Employee (TTM) | -1,634,153 | 2,194,067 | 106,550,787 | |
| Receivable Turnover (TTM) | 1.72 | 18.46 | 5.94 | |
| Inventory Turnover (TTM) | -- | 2.61 | 3.62 | |
| Asset Turnover (TTM) | 0.00 | 0.43 | 0.97 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -106.72 | -1.11 | 11.50 | |
| Return on Assets - 5 Yr. Avg. | -79.87 | 2.88 | 12.67 | |
| Return on Investment (TTM) | -129.83 | 0.28 | 15.02 | |
| Return on Investment - 5 Yr. Avg. | -89.70 | 1.84 | 16.45 | |
| Return on Equity (TTM) | -133.51 | 0.94 | 16.60 | |
| Return on Equity - 5 Yr. Avg. | -90.58 | 2.30 | 17.56 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 0.00 | 0.00 | -- |
| EPS (TTM) % | -15.71 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for TG Therapeutics Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 0.82 | -2.66 | 88 | 57 |
| 13 Week | 19.42 | 13.60 | 99 | 62 |
| 26 Week | 16.59 | 7.73 | 99 | 81 |
| 52 Week | 46.08 | 23.82 | 99 | 47 |
| YTD | 164.52 | 132.30 | 99 | 60 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 64.23% |
| # of Holders: | 175 |
| Total Shares Held: | 53,242,739 |
| 3 Mo. Net Change: | 6,165,642 |
| # New Positions: | 26 |
| # Closed Positions: | 33 |
| # Increased Positions: | 91 |
| # Reduced Positions: | 71 |
| # Net Buyers: | 20 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.